Green synthesis of bioactive oligopeptides promoted by recyclable nanocrystalline hydroxyapatite
Abstract
Aim: The pharmaceutical industry is showing renewed interest in therapeutic peptides. Unfortunately, the chemical synthesis of peptides remains very expensive and problematic in terms of environmental sustainability. Hence, making peptides ‘greener’ has become a new front line for the expansion of peptide market. Results: We developed a mechanochemical solvent-free peptide bond-forming protocol using standard reagents and nanocrystalline hydroxyapatite as a bio-compatible, reusable inorganic base. The reaction was also conducted under ultra-mild, minimal solvent-grinding conditions, using common laboratory equipment. Conclusion: The efficacy of the described protocol was validated with the convenient preparation of endomorphin-1, H-Tyr-Pro-Trp-Phe-NH2, the endogenous ligand of the μ-opioid receptor, currently regarded as a lead for the discovery of painkillers devoid of harmful side effects.
Graphical abstract
Papers of special note have been highlighted as: • of interest; •• of considerable interest
References
- 1. . Peptides and peptidomimetics in medicine, surgery and biotechnology. Curr. Med. Chem. 13(20), 2449–2466 (2006).
- 2. . The current state of peptide drug discovery: back to the future? J. Med. Chem. 61(4), 1382–1414 (2018).
- 3. . Chemical modifications designed to improve peptide stability: incorporation of non-natural amino acids, pseudo-peptide bonds, and cyclization. Curr. Pharm. Des. 16(28), 3185–3203 (2010).
- 4. . Manufacturing peptides as active pharmaceutical ingredients. Future Med. Chem. 1(2), 361–377 (2009).
- 5. . Modern tools for the chemical ligation and synthesis of modified peptides and proteins. Future Med. Chem. 8(18), 2287–2304 (2016).
- 6. . Green transformation of solid-phase peptide synthesis. ACS Sustain. Chem. Eng. 7(4), 3671–3683 (2019). •• A comprehensive review on recent green techniques, reagents, solvents, for solid phase and liquid peptide synthesis.
- 7. Sustainability challenges in peptide synthesis and purification: from R&D to production. J. Org. Chem. 84(8), 4615–4628 (2019).
- 8. . Making solid-phase peptide synthesis greener: a review of the literature. Chem. Asian J. 14(8), 1088–1097 (2019).
- 9. . A survey of solvent selection guides. Green Chem. 16(10), 4546–4551 (2014).
- 10. CHEM21 selection guide of classical and less classical-solvents. Green Chem. 18(1), 288–296 (2016). •• A methodology based on safety, health and environment criteria enables a greenness evaluation of bio-derived solvents.
- 11. Tools and techniques for solvent selection: green solvent selection guides. Sustain. Chem. Process 4(7),
doi:10.1186/s40508-016-0051-z (2016). - 12. . Aqueous microwave-assisted solid-phase synthesis using Boc-amino acid nanoparticles. Appl. Sci. 3(3), 614–623 (2013).
- 13. . Controlled solid phase peptide bond formation using N-carboxyanhydrides and PEG resins in water. ACS Sustain. Chem. Eng. 1(6), 566–569 (2013). •• Solid-phase synthesis of peptides is conducted in aqueous medium with excellent atom economy, without the need of protecting groups nor activating agents.
- 14. . Tandem deprotection/coupling for peptide synthesis in water at room temperature. Green Chem. 19(18), 4263–4267 (2017).
- 15. . Solid-phase peptide synthesis in water using microwave-assisted heating. Org. Lett. 11(20), 4488–4491 (2009). • A method for the solid-phase synthesis of peptides using the most common Boc-amino acid derivatives was developed, using polyethylene glycol (PEG)-based resin, N-ethyl-N′-(3-dimethylaminopropyl)carbodiimide-HONB as a coupling method, and microwave (MW) irradiation as an energy source.
- 16. . A fast and easy strategy for protein purification using “teabags”. Sci. Rep. 6, 28887 (2016).
- 17. . Synthesis and application of peptide arrays: quo vadis SPOT technology. ChemBioChem 10(9), 1431–1442 (2009).
- 18. . Solvent-free synthesis of peptides. Angew. Chem. Int. Ed. 48(49), 9318–9321 (2009). •• Here is reported a straightforward, high-yielding method for the preparation of peptides with no epimerization and in the absence of solvent, involving the reaction of Boc-N-carboxyanhydrides.
- 19. . Mechanochemical synthesis of dipeptides using Mg–Al hydrotalcite as activating agent under solvent-free reaction conditions. Eur. J. Org. Chem. 2017(3), 687–694 (2017). •• Mg–Al hydrotalcite minerals as green activating agent offered several advantages: the use of readily available reagents and inexpensive materials, easy workup, simple recovery and recyclability, and short reaction times.
- 20. N-Acyl benzotriazole derivatives for the synthesis of dipeptides and tripeptides and peptide biotinylation by mechanochemistry. ACS Sustain. Chem. Eng. 5(4), 2936–2941 (2017).
- 21. . Green synthesis of α,β- and β,β-dipeptides under solvent-free conditions. J. Org. Chem. 75(21), 7107–7111 (2010). •• N-Boc-N-carboxyanhydrides were employed under ball-milling activation, giving α,β- and β,β-dipeptides.
- 22. Peptide synthesis: ball-milling, in solution, or on solid support, what is the best strategy? Beilstein J. Org. Chem. 13, 2087–2093 (2017).
- 23. . Mechanoenzymatic peptide and amide bond formation. Green Chem. 19(11), 2620–2625 (2017). •• Mechanochemical chemoenzymatic peptide and amide bond formation catalyzed by papain was studied by ball milling.
- 24. . Papain-catalysed mechanochemical synthesis of oligopeptides by milling and twin-screw extrusion: application in the Juliá-Colonna enantioselective epoxidation. Green Chem. 20(6), 1262–1269 (2018).
- 25. . Environmentally benign peptide synthesis using liquid-assisted ball milling: application to the synthesis of Leu-enkephalin. Green Chem. 15(5), 1116–1120 (2013). • An original methodology for peptide bond synthesis avoiding toxic solvents and reactants was successfully applied to the synthesis of Leu-enkephalin.
- 26. . Peptide mechanosynthesis by direct coupling of N-protected α-amino acids with amino esters. Eur. J. Org. Chem. 2016(21), 3505–3508 (2016).
- 27. Efficient activity of magnesium–aluminium hydrotalcite in the synthesis of amides. RSC Adv. 3(45), 23046–23050 (2013).
- 28. . Functionalized biomimetic calcium phosphates for bone tissue repair. J. Appl. Biomater. Funct. Mater. 15(4), e313–e325 (2017).
- 29. . (9R)-9-Hydroxystearate-functionalized anticancer ceramics promote loading of silver nanoparticles. Nanomaterials 8(6), E390 (2018).
- 30. . Deformable biomaterials based on ultralong hydroxyapatite nanowires. ACS Biomater. Sci. 5(10), 4951–4961 (2019).
- 31. . Recent advances in the synthesis, functionalization and biomedical applications of hydroxyapatite: a review. RSC Adv. 7(13), 7442–7458 (2017).
- 32. . Hydroxyapatite for poly(α-hydroxy esters) biocomposites applications. Polym. Rev. 59(2), 187–239 (2019).
- 33. . Biomimetic hydroxyapatite on graphene supports for biomedical applications: a review. Nanomaterials 9(10), 1435 (2019)
- 34. . A brief review on hydroxyapatite production and use in biomedicine. Ceramica 65, 282–302 (2019).
- 35. . Luminescent hydroxyapatite doped with rare earth elements for biomedical applications. Nanomaterials 9(2), 239 (2019).
- 36. . Hydroxyapatite: a review of syntheses, structure and applications in heterogeneous catalysis. Coord. Chem. Rev. 347, 48–76 (2017). • The significant applications of hydroxyapatite both as an inorganic support and as a catalyst are described with an emphasis on its performance, stability and reusability.
- 37. . Design of high-performance heterogeneous catalysts using apatite compounds for liquid-phase organic syntheses. ACS Catalysis 7(2), 920–935 (2017).
- 38. Control of calcium accessibility over hydroxyapatite by post-precipitation steps: influence on the catalytic reactivity toward alcohols. Phys. Chem. Chem. Phys. 18(40), 27837–27847 (2016).
- 39. . Importance of the nature of the active acid/base pairs of hydroxyapatite involved in the catalytic transformation of ethanol to n-butanol revealed by operando DRIFTS. ChemCatChem 11(6), 1765–1778 (2019).
- 40. Identification of surface basic sites and acid-base pairs of hydroxyapatite. J. Phys. Chem. C 118(24), 12744–12757 (2014).
- 41. . The role of amino acids in hydroxyapatite mineralization. J. R. Soc. Interface 13(123), 20160462 (2016).
- 42. . Approach toward the understanding of coupling mechanism for EDC reagent in solvent-free mechanosynthesis. Org. Lett. 19(19), 5360–5363 (2017). • Solid-state nuclear magnetic resonance, x-ray crystallography and theoretical calculations are employed to study the mechanism of the formation of the C–N amide bond using N-ethyl-N′-(3-dimethylaminopropyl)carbodiimide·HCl.
- 43. . Microstructural investigation of hydroxyapatite–polyelectrolyte composites. J. Mater. Chem. 14(2), 274–279 (2004).
- 44. . FTIR and electron microscopy observed consequences of HCl and CO2 interfacial interactions with synthetic and biological apatites: influence of hydroxyapatite maturity. Mater. Chem Phys. 221, 332–341 (2019).
- 45. . A novel aromatic carbocation-based coupling reagent for esterification and amidation reactions. Chem. Commun. 51(15), 3131–3134 (2015).
- 46. . Structural and morphological consequences of high-temperature treatments of hydroxyapatite in the absence or presence of HCl vapor. Langmuir 22(2), 749–755 (2006).
- 47. . ReGreen SPPS: enabling circular chemistry in environmentally sensible solid-phase peptide synthesis. Green Chem. 21(21), 5990–5998 (2019).
- 48. Green solid-phase peptide synthesis 2. 2-Methyltetrahydrofuran and ethyl acetate for solid-phase peptide synthesis under green conditions. ACS Sustain. Chem. Eng. 4, 6809–6814 (2016). • Green solvents, temperature, solid supports and peptide models were evaluated in this study to establish the best green protocol.
- 49. . Design and characterization of opioid ligands based on cycle-in-macrocycle scaffold. Bioorg. Med. Chem. 25(8), 2399–2405 (2017).
- 50. . Tryptophan-containing non-cationizable opioid peptides – a new chemotype with unusual structure and in vivo activity. Future Med. Chem. 9(17), 2099–2115 (2017).
- 51. Endomorphin-2 analogs containing modified tyrosines: biological and theoretical investigation of the influence on conformation and pharmacological profile. Eur. J. Med. Chem. 179, 527–536 (2019).
- 52. Constraining endomorphin-1 by β,α-hybrid dipeptide/heterocycle scaffolds: identification of a novel κ-opioid receptor selective partial agonist. J. Med. Chem. 61(13), 5751–5757 (2018). •• The modification of the mu-opioid receptor agonist edomorphin-1 resulted in a new chemotype of selective, partial KOR agonist inducing analgesia, therefore displaying great potential interest as a painkiller possibly with reduced harmful side effects.
- 53. . A potent and selective endogenous agonist for the mu-opiate receptor. Nature 386(6624), 499–502 (1997). •• The tetrapeptides edomorphin-1 and -2 were identified in mammalian and were recognized to be endogenous agonists for the mu opioid receptor.
- 54. . Efficient chemo-enzymatic synthesis of endomorphin-1 using organic solvent stable proteases to green the synthesis of the peptide. Green Chem. 13(7), 1680–1685 (2011). • The chemo-enzymatic synthesis of edomorphin-1 proved to be productive, with minimal side-chain protection and simple purification, thus validating the chemo-enzymatic approach for peptide synthesis.